BMS 6072 (Glucovance 1.25 mg / 250 mg)
Generic Name: glyburide/metformin
Pill with imprint BMS 6072 is Yellow, Elliptical / Oval and has been identified as Glucovance 1.25 mg / 250 mg. It is supplied by Bristol-Myers Squibb.
Glucovance is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. There is no proven risk in humans during pregnancy. Glucovance 1.25 mg / 250 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for BMS 6072
Glucovance
- Generic Name:
- glyburide/metformin
- Imprint:
- BMS 6072
- Strength:
- 1.25 mg / 250 mg
- Color:
- Yellow
- Size:
- 13.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Antidiabetic combinations
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Bristol-Myers Squibb
- Inactive Ingredients:
- microcrystalline cellulose
povidone
croscarmellose sodium
magnesium stearate
Note: Inactive ingredients may vary.
Labelers / Repackagers:
| NDC Code | Labeler / Repackager |
|---|---|
| 00087-6072 | Bristol-Myers Squibb Company |
| 54868-4906 | Physicians Total Care Inc. (repackager) |
More about Glucovance (glyburide / metformin)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- En Español
- 2 Reviews
- Drug class: antidiabetic combinations
- FDA Alerts (1)
Consumer resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
